Analystreport

Mersana Therapeutics Inc (NASDAQ: MRSN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana